Homonal treatment data

Simon Tegg made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Simon Tegg

Dear Pharmaceutical Management Agency,

Thankyou for your response to request:2023-24-115.

I request incidence and prevalence data on the number of individuals <18 years old dispensed hormone treatments.

For NHI sexes: "female" "male" "other" and "unknown":
1. Incidence (number of individuals to whom drug was newly dispensed in a calendar year who were not dispensed to in the previous calendar year):
- Testosterone
- Oestrogen
- Antiandrogens (Spironolactone, Cyproterone)
By sex, calendar year 2006 through 2023, and specific age at dispensing 0, 1, 2,...15, 16, 17.

2. Prevalence (number individuals dispensed to in the calendar year) as above.

Best,

Simon Tegg

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Kia ora Simon

Thank you for your request for information, received by Pharmac on 1 April 2024. Your request has been received and logged. Our reference number for your request is: 2023-24-157.

As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 1 May 2024.

If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.

Please feel free to contact us if you require any further assistance.

Ngâ mihi,

Katy Carlson (she/her) | Government Services Advisor
___________________________________________________________________
Te Pâtaka Whaioranga – Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 |http://www.pharmac.govt.nz/

-----Original Message-----
From: Simon Tegg <[FYI request #26280 email]>
Sent: Monday, April 1, 2024 7:22 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - Homonal treatment data

[You don't often get email from [FYI request #26280 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmaceutical Management Agency,

Thankyou for your response to request:2023-24-115.

I request incidence and prevalence data on the number of individuals <18 years old dispensed hormone treatments.

For NHI sexes: "female" "male" "other" and "unknown":
1. Incidence (number of individuals to whom drug was newly dispensed in a calendar year who were not dispensed to in the previous calendar year):
- Testosterone
- Oestrogen
- Antiandrogens (Spironolactone, Cyproterone) By sex, calendar year 2006 through 2023, and specific age at dispensing 0, 1, 2,...15, 16, 17.

2. Prevalence (number individuals dispensed to in the calendar year) as above.

Best,

Simon Tegg

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FYI request #26280 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Oliver Whitehead
Pharmaceutical Management Agency


Attachment 2024 04 30 Response letter Official Information request.pdf
122K Download View as HTML

Attachment 2024 04 Hormonal Treatment data for release.xlsx
55K Download View as HTML


Kia ora Simon,

Please find a response to your request attached to this email.

Oliver

-----Original Message-----
From: Web Enquiry
Sent: Tuesday, April 2, 2024 12:50 PM
To: 'Simon Tegg' <[FOI #26280 email]>
Subject: 2023-24-157 - Acknowledgement - RE: Official Information request - Homonal treatment data

Kia ora Simon

Thank you for your request for information, received by Pharmac on 1 April 2024. Your request has been received and logged. Our reference number for your request is: 2023-24-157.

As required under the Official Information Act 1982, we will respond to your request within 20 working days. You should receive a response on or before 1 May 2024.

If a large amount of information has been requested, we may need to extend this date (this is provided for in section 15A of the Act). We will advise you if such an extension is necessary.

Please feel free to contact us if you require any further assistance.

Ngâ mihi,

Katy Carlson (she/her) | Government Services Advisor ___________________________________________________________________
Te Pâtaka Whaioranga – Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 |http://www.pharmac.govt.nz/

-----Original Message-----
From: Simon Tegg <[FOI #26280 email]>
Sent: Monday, April 1, 2024 7:22 PM
To: Web Enquiry <[email address]>
Subject: Official Information request - Homonal treatment data

[You don't often get email from [FOI #26280 email]. Learn why this is important at https://aka.ms/LearnAboutSenderIdentific... ]

Dear Pharmaceutical Management Agency,

Thankyou for your response to request:2023-24-115.

I request incidence and prevalence data on the number of individuals <18 years old dispensed hormone treatments.

For NHI sexes: "female" "male" "other" and "unknown":
1. Incidence (number of individuals to whom drug was newly dispensed in a calendar year who were not dispensed to in the previous calendar year):
- Testosterone
- Oestrogen
- Antiandrogens (Spironolactone, Cyproterone) By sex, calendar year 2006 through 2023, and specific age at dispensing 0, 1, 2,...15, 16, 17.

2. Prevalence (number individuals dispensed to in the calendar year) as above.

Best,

Simon Tegg

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #26280 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Simon Tegg

Dear Pharmac,

Thankyou for this response,

I additionally request Oestradiol in the same format as requested previously. This may include Oestradiol valerate (Progynova) and Oestradiol patch (Estradot)

Yours sincerely,

Simon Tegg

Link to this

From: OIA Secondment
Pharmaceutical Management Agency

Kia ora,

 

Thank you for your request for information under the Official Information
Act 1982 (OIA) request of 5 May 2024. You requested:

 

I additionally request Oestradiol in the same format as requested
previously. This may include Oestradiol valerate (Progynova) and
Oestradiol patch (Estradot)

 

You will receive a response on or before 31 May 2024, and no later than 20
working days after the date of your request.

 

Thank you

 

Government Services  

___________________________________________________________________
Pharmac - Te Pātaka Whaioranga | Level 9, 40 Mercer Street, Wellington
[1]www.pharmac.govt.nz

 

 

-----Original Message-----

From: Simon Tegg <[2][FOI #26280 email]>

Sent: Sunday, May 5, 2024 6:31 PM

To: Oliver Whitehead <[3][email address]>

Subject: RE: 2023-24-157 - Acknowledgement - RE: Official Information
request - Homonal treatment data

 

Dear Pharmac,

 

Thankyou for this response,

 

I additionally request Oestradiol in the same format as requested
previously. This may include Oestradiol valerate (Progynova) and
Oestradiol patch (Estradot)

 

Yours sincerely,

 

Simon Tegg

 

-----Original Message-----

 

Kia ora Simon,

 

Please find a response to your request attached to this email.

 

Oliver

 

-------------------------------------------------------------------

Please use this email address for all replies to this request:

[4][FOI #26280 email]

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[5]https://aus01.safelinks.protection.outlo...

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

-------------------------------------------------------------------

 

This e-mail message and any accompanying attachments may contain
confidential information. If you are not the intended recipient, please do
not read, use, disseminate, distribute or copy this message or
attachments. If you have received this message in error, please notify the
sender immediately and delete this message.

References

Visible links
1. http://www.pharmac.govt.nz/
2. mailto:[FOI #26280 email]
3. mailto:[email address]
4. mailto:[FOI #26280 email]
5. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

From: OIA Secondment
Pharmaceutical Management Agency

Kia ora Simon,

In order to progress your request, we have a few details that need clarifying. Can you please advise on the following points on the information you are interested in:

1. Are you interested in all of formulations and the brands associate to them for Oestradiol's?
2. or are you only interested in getting the information about Oestradiol valerate (Progynova) and Oestradiol patch (Estradot)?
3. For Tabs we have Oestradiol with levonorgestrel and Oestradiol with norethisterone , will you be interested in knowing about them too?

Please note, the 20 working days for Pharmac to answer your request is re-calculated from the day we receive your refinement, in accordance with section 15(1AA) of the Official Information Act 1982.

Ngā mihi,
Government Services
Pharmac

-----Original Message-----
From: Simon Tegg <[FOI #26280 email]>
Sent: Sunday, May 5, 2024 6:31 PM
To: Oliver Whitehead <[email address]>
Subject: RE: 2023-24-157 - Acknowledgement - RE: Official Information request - Homonal treatment data

Dear Pharmac,

Thankyou for this response,

I additionally request Oestradiol in the same format as requested previously. This may include Oestradiol valerate (Progynova) and Oestradiol patch (Estradot)

Yours sincerely,

Simon Tegg

-----Original Message-----

Kia ora Simon,

Please find a response to your request attached to this email.

Oliver

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #26280 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Simon Tegg

Dear Pharmac,

Thanks for the clarification. I am interested in all formulations and brands of Oestradiol not just the brands I mentioned.

Simon Tegg

Link to this

From: OIA Secondment
Pharmaceutical Management Agency

Thank you Simon, we will progress your request.

Please note, the timeframe for response has been reset following clarification. As such, you will receive a response within the next 20 working days and no later than 11 June 2024.

Ngā mihi,
Government Services
Pharmac

-----Original Message-----
From: Simon Tegg <[FOI #26280 email]>
Sent: Tuesday, May 14, 2024 8:10 AM
To: OIA Secondment <[email address]>
Subject: RE: 2023-24-157 - Acknowledgement - RE: Official Information request - Homonal treatment data

Dear Pharmac,

Thanks for the clarification. I am interested in all formulations and brands of Oestradiol not just the brands I mentioned.

Simon Tegg

-----Original Message-----

Kia ora Simon,

In order to progress your request, we have a few details that need clarifying. Can you please advise on the following points on the information you are interested in:

1. Are you interested in all of formulations and the brands associate to them for Oestradiol's?
2. or are you only interested in getting the information about Oestradiol valerate (Progynova) and Oestradiol patch (Estradot)?
3. For Tabs we have Oestradiol with levonorgestrel and Oestradiol with norethisterone , will you be interested in knowing about them too?

Please note, the 20 working days for Pharmac to answer your request is re-calculated from the day we receive your refinement, in accordance with section 15(1AA) of the Official Information Act 1982.

Ngā mihi,
Government Services
Pharmac

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #26280 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment Response to FW 2023 24 157 RE Official Information request Homonal treatment data.pdf
105K Download View as HTML

Attachment OIA release Tegg Oestradiol.xlsx
178K Download View as HTML


Kia ora,

Please find attached a response to your Official Information Act request of 5 May 2024.

Thank you
Government Services - Pharmac

-----Original Message-----
From: Simon Tegg <[FOI #26280 email]>
Sent: Sunday, May 5, 2024 6:31 PM
To: Oliver Whitehead <[email address]>
Subject: RE: 2023-24-157 - Acknowledgement - RE: Official Information request - Homonal treatment data

Dear Pharmac,

Thankyou for this response,

I additionally request Oestradiol in the same format as requested previously. This may include Oestradiol valerate (Progynova) and Oestradiol patch (Estradot)

Yours sincerely,

Simon Tegg

-----Original Message-----

Kia ora Simon,

Please find a response to your request attached to this email.

Oliver

-------------------------------------------------------------------
Please use this email address for all replies to this request:
[FOI #26280 email]

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: